Erlotinib and confusional state Patient Reports February 11, 2012

Erlotinib Side Effects Report #5343731-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 25, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bile duct obstruction, blood glucose decreased, cholangitis, confusional state, pneumonia aspiration, respiratory distress, respiratory failure. Erlotinib dosage: 100MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5481996-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bile duct obstruction, bile duct stenosis, blood glucose decreased, cholangitis, confusional state, disease progression, pneumonia aspiration, respiratory distress. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOLOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5498435-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 08, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bile duct obstruction, blood glucose decreased, cholangitis, confusional state, disease progression, malignant hepatobiliary neoplasm, pneumonia aspiration, prothrombin time prolonged. Erlotinib dosage: 100MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5744847-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, blood sodium decreased, candidiasis, confusional state, dehydration, haematocrit decreased, haemoglobin decreased, herpes simplex . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5764810-0
Erlotinib side effect was reported by a Physician from UNITED STATES on May 19, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, ascites, asthenia, blood albumin decreased, candidiasis, confusional state, dehydration, failure to thrive. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient died on 05/17/2008.

Erlotinib Side Effects Report #5224657-0
Erlotinib side effect was reported by a Physician from DENMARK on Jan 10, 2007. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, memory impairment, metastases to central nervous system. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, EMPERAL, PAMOL, OXAZEPAM, MAGNESIUM HYDROXIDE, MORPHINE, POTASSIUM CHLORIDE, ZOPICLONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5165198-9
Erlotinib side effect was reported by a Health Professional from DENMARK on Nov 08, 2006. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, haemorrhage, memory impairment, metastases to central nervous system. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with BAVACIZUMAB, EMPERAL, PAMOL, OXAZEPAM, MAGNESIUM HYDROXIDE, MORPHINE, POTASSIUM CHLORIDE, ZOPICLONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5772994-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 27, 2008. Female patient, 53 years of age, weighting 235.9 lb, was diagnosed with ovarian cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, blood chloride decreased, blood chloride increased, blood culture positive, cardiomegaly, cellulitis , confusional state, diarrhoea. Erlotinib dosage: 250 MG, DAYS 2-16/Q3W), ORAL. During the same period patient was treated with ALIMTA, XANAX, PERCOCET, DECADRON, MODUCAL, LIPITOR, AMBIEN, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6106825-9
Erlotinib side effect was reported by a Physician from FRANCE on Feb 17, 2009. Female patient, 82 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state. Erlotinib dosage: unknown. During the same period patient was treated with TRIATEC, ATORVASTATIN CALCIUM, TRAMADOL, ACETAMINOPHEN, FORLAX, SPIRIVA, FORADIL, INNOHEP. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5038207-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 19, 2006. Female patient, 80 years of age, weighting 147.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, disorientation, dizziness , flat affect, mental status changes, syncope. Erlotinib dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with AVASTIN, CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5721627-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 28, 2008. Female patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state. Erlotinib dosage: 150 MG DAILY PO. During the same period patient was treated with BEVACIZUMAB, FENTANYL TRANSDERMAL SYSTEM, EFFEXOR, DILTIAZEM, OXYCODON, CALCIUM, FISH OIL, SENNA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5772073-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 12, 2008. Female patient, 78 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: agitation, confusional state, delusional disorder, persecutory type, depression , mental status changes. Erlotinib dosage: 150 MG DAILY PO. During the same period patient was treated with BEVACIZUMAB, FENTANYL, EFFEXOR, DILTIAZEM, OXYCODEN, CALCIUM, FISH OIL, SENNA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5277737-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient, 75 years of age, weighting 129.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood glucose increased, confusional state, convulsion, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypomagnesaemia, mucosal dryness. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5776185-1
Erlotinib side effect was reported by a Physician from AUSTRALIA on May 29, 2008. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diarrhoea, haemoglobin increased, hypomagnesaemia, neutropenia, somnolence, thrombocytopenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ASPIRIN, METFORMIN, MELIZIDE, PERINDOPRIL ERBUMINE, SIMVASTATIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5958887-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 03, 2008. Male patient, 75 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood urea increased, confusional state, csf test abnormal, decreased appetite, infection protozoal, memory impairment, mental status changes, metastases to central nervous system, streptococcal bacteraemia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #5977026-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2008. Male patient, 75 years of age, weighting 173.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, cerebral ischaemia, confusional state, hyponatraemia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with SUNITINIB, TYLENOL W, BENADRYL, MOTRIN, XALATAN, REMERON, DOXYCYCLINE HYCLATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6120247-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Male patient, 75 years of age, weighting 173.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral infarction, confusional state, gait disturbance, hyponatraemia, impulsive behaviour. Erlotinib dosage: 150 MG, QD), ORAL. During the same period patient was treated with VITAMIN, TYLENOL WITH CODEINE, BENADRYL, MOTRIN, XALATAN, REMERON, DOXYCYCLINE HYCLATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5960396-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 14, 2008. Female patient, 74 years of age, weighting 112.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, hypertension. Erlotinib dosage: UNK MG, UNK. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5913983-5
Erlotinib side effect was reported by a Health Professional from FRANCE on Sept 22, 2008. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DOXYCYCLINE, ALPRAZOLAM, PRAVASTATIN, CALCIPRAT D, PAROXETINE HYDROCHLORIDE, TIMOPTIC, CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6009087-6
Erlotinib side effect was reported by a Consumer or non-health professional from FRANCE on Dec 02, 2008. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dementia , disease progression, hyperthyroidism. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DOXYCYCLINE, ALPRAZOLAM, PRAVASTATIN, CALCIPRAT D, PAROXETINE HYDROCHLORIDE, TIMOPTIC, CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6023554-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2008. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6028903-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2009. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, faecal incontinence, lethargy, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4544984-X
Erlotinib side effect was reported by a Physician from on Dec 14, 2004. Female patient, 69 years of age, weighting 175.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, disorientation, erythema, prothrombin time prolonged, pruritus, rash , skin discolouration. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PROPINE EYE DROPS, XALATAN EYE GTTS. Patient recovered.

Erlotinib Side Effects Report #5163211-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 07, 2006. Female patient, 68 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, disorientation. Erlotinib dosage: 1500 MG QD ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, ACETAMINOPHEN, ZETIA, ATIVAN, ASCORBIC ACID, FOLIC ACID, LOVENOX. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5535090-6
Erlotinib side effect was reported by a Physician from CANADA on Nov 16, 2007. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diarrhoea, disease progression, hypotension, somnolence. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PIOGLITAZONE, RABEPRAZOLE, TRAZODONE, LEVOTHYROXINE, PAROXETINE, EPREX, CIPROFLOXACIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5955949-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 27, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, candidiasis, confusional state, cough, dehydration, dysphagia, electrolyte imbalance, mental status changes. Erlotinib dosage: (50 MG, QD), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5156702-5
Erlotinib side effect was reported by a Health Professional from UNITED KINGDOM on Oct 30, 2006. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: balance disorder, cerebral calcification, confusional state, disorientation, dysarthria, encephalopathy, fall , lung cancer metastatic, malignant neoplasm progression. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with WARFARIN, THIAMIN, VITAMIN B, LANSOPRAZOLE. Patient was hospitalized. Patient died on 03/08/2005.

Erlotinib Side Effects Report #4628550-3
Erlotinib side effect was reported by a Health Professional from on Feb 28, 2005. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: balance disorder, confusional state, disease progression, dysarthria, encephalopathy, fall , metastases to bone, somnolence. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with WARFARIN, THIAMIN, VITAMIN B, LANSOPRAZOLE. Patient was hospitalized. Patient died on 03/08/2005.

Erlotinib Side Effects Report #6128211-8
Erlotinib side effect was reported by a Physician from CANADA on Mar 06, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abasia, aphasia , confusional state, meningeal disorder. Erlotinib dosage: 150 MG, ORAL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #4746424-4
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on July 28, 2005. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature increased, coma, confusional state, hemiparesis, loss of consciousness, meningeal disorder. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ISOSORBIDE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140788-5
Erlotinib side effect was reported by a Physician from GREECE on Mar 17, 2009. Male patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dizziness , dysarthria, fatigue, metastases to central nervous system. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5993049-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 10, 2008. Male patient, 60 years of age, weighting 229.1 lb, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , confusional state, irritable bowel syndrome , mental status changes. Erlotinib dosage: 150 MG ORAL ONCE DAILY. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5781093-6
Erlotinib side effect was reported by a Physician from UNITED STATES on June 03, 2008. Male patient, weighting 163.1 lb, was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, disorientation, pleural effusion. Erlotinib dosage: 150 MG,QD,DAYS 1-28,ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5484270-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 25, 2007. Male patient, 55 years of age, weighting 143.0 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, confusional state, glioblastoma multiforme, hemiparesis, malignant neoplasm progression, somnolence, visual acuity reduced. Erlotinib dosage: 150 MG (150 MG, QD), ORAL, 150 MG (200 MG, QD), ORAL. During the same period patient was treated with INSULIN, DECADRON, KEPPRA, HYDROCHLOROTHIAZIDE, FELODIPINE, GABAPENTIN. Patient died on 07/28/2007.


Erlotinib Side Effects Report #5074815-3
Erlotinib side effect was reported by a Physician from UNITED STATES on May 18, 2006. Male patient, 54 years of age, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diverticulum intestinal, electrolyte imbalance, febrile neutropenia, large intestine perforation, pancytopenia, sepsis . Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, SULFAMETHOXAZOLE, LEVAQUIN, OLANZAPINE. Patient died on 02/13/2006.

Erlotinib Side Effects Report #5020579-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2006. Male patient, 54 years of age, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diverticular perforation, diverticulum intestinal, febrile neutropenia, gastrointestinal perforation, pancytopenia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, SULFAMETHOXAZOLE, LEVAQUIN, OLANZAPINE. Patient died on 02/13/2006.

Erlotinib Side Effects Report #5748745-5
Erlotinib side effect was reported by a Physician from UNITED STATES on May 07, 2008. Male patient, weighting 166.0 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, convulsion. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with TEMSIROLIMUS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5681116-9
Erlotinib side effect was reported by a Physician from DENMARK on Mar 10, 2008. Female patient, 66 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, pulmonary oedema, pyrexia, somnolence. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CONTALGIN, DURAGESIC, IMOZOP, MOTRIN, OMEPRAZOLE, MOVICOL, TRADOLAN. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #4814847-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Male patient, weighting 154.3 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, confusional state, dehydration, diarrhoea, failure to thrive, laboratory test interference, orthostatic hypotension. Erlotinib dosage: 100MG QD ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5125290-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 67 years of age, weighting 163.8 lb, was diagnosed with carcinoid tumour and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, anorexia, asthenia, chest pain , confusional state, dehydration, diarrhoea, fatigue. Erlotinib dosage: unknown. During the same period patient was treated with GLYBURIDE, FERROUS SULPHATE, KEPPRA, LORTAB, SANDOSTATIN, ZOMETA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6069108-1
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 20, 2009. Female patient, 53 years of age, was diagnosed with brain neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, confusional state, white blood cell count increased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with OXYCONTIN, GABAPENTIN, MORPHINE SULPHATE, DICLOFENAC, DOMPERIDONE, RANITIDINE, LOPERAMIDE, TRAMADOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5222614-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 08, 2007. Male patient, 56 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspiration, blood chloride increased, blood pressure decreased, blood sodium increased, carbon dioxide decreased, coagulopathy, confusional state, gastrointestinal haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, DILAUDID, OXYCONTIN, VICODIN, MAGNESIUM CHLORIDE, PHENERGAN, MARINOL, TUSSINEX. Patient was hospitalized. Patient died.